We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Minimally Invasive Transoral Surgery Treats Heartburn

By HospiMedica International staff writers
Posted on 13 Apr 2011
A surgical procedure called transoral incisionless fundoplication (TIF) offers an alternative to patients suffering from gastroesophageal reflux disease (GERD) for whom daily treatments with proton pump inhibitors (PPIs) is inadequate.

The procedure is performed using the EsophyX device, an innovative natural orifice surgery (NOS) device to treat GERD that creates a robust 2 cm - 3 cm, 270° - 320° transoral esophagogastric fundoplication. More...
The device is comprised of a tissue mold and chassis used to compress and wrap tissue around esophagus; a helical retractor that anchors, retracts, and elongates tissue by radial manipulation, which is positioned inside the tissue mold during insertion and removal; an invaginator for circumferential retraction of esophageal tissue that allows reduction and elimination of a hiatal hernia of up to 2 cm; and stylets and fasteners to maintain tissue compression throughout healing process.

The EsophyX device is introduced transorally and advanced into the esophagus under visualization of a video camera inserted down the central shaft of the device. It is then used to form and fasten several tissue folds (plications), creating a robust antireflux valve at the gastroesophageal junction and tightening the lower esophageal sphincter (LES), thus reestablishing a barrier to reflux and restoring the competency of the gastroesophageal junction. Advantages of TIF incisionless surgery over conventional laparoscopic or open GERD surgery include shorter hospital stay, reduced patient discomfort, shortened patient recovery, no visible scars, and typically higher patient satisfaction. The EsophyX device is a product of Endogastric Solutions (Redmond, WA, USA).

"The TIF procedure recreates the antireflux barrier between the esophagus and stomach and is performed transorally,” said Benjamin Havemann, MD, a gastroenterologist at Scott & White Healthcare - Round Rock (Temple, TX, USA). "The procedure can reduce a small hiatal hernia and creates a valve between the stomach and esophagus restoring the natural, physiological anatomy to prevent reflux. Because the procedure is incisionless, there is reduced pain, shorter recovery time required, and no visible scar.”

Related Links:
Endogastric Solutions
Scott & White Healthcare - Round Rock


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Glucose Meter
StatStrip®
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.